Her rheumatologist instructed her to undergo a baseline ocular examination prior to initiating Plaquenil (hydroxychloroquine, Sanofi-Aventis) therapy. Toxic maculopathy associated with chloroquine use was first documented in the literature five decades ago.1 In the United States, Plaquenil––an analog to chloroquine––is used to treat a variety of conditions, including rheumatoid arthritis, lupus and several distinct inflammatory disorders. Although the incidence of macular toxicity is infrequent with Plaquenil use (at a dosage of 200mg or 400mg q.d.), its visual impact can be devastating. Plaquenil medication insert Hydroxychloroquine for frontal fibrosing alopecia How do you know if plaquenil is working What happens if i stop taking my plaquenil The Royal College of Ophthalmologists - Hydroxychloroquine and Ocular Toxicity Recommendations on Screening – October 2009 Dubois EL, Tuffanelli DL Clinical manifestations of systemic lupus erythematosus. Computer analysis of 520 cases. JAMA. 1964;14-111. Mar 15, 2019 Marmor MF, Kellner U, Lai TY, Melles RB, Mieler WF, American Academy of Ophthalmology. Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy 2016 Revision. Ophthalmology. 2016 Jun. 123 61386-94. Mason CG. Ocular accumulation and toxicity of certain systemically administered drugs. The Royal College of Ophthalmologists—Hydroxychloroquine and Ocular Toxicity. Recommendations on Screening, October 2009. 9. Frederick W, Marmor MF. Rates and predictors of hydroxychloroquine retinal toxicity in patients with rheumatoid arthritis and systemic lupus erythematosus. Initially, central visual acuity may be unaffected, but the patient may notice related paracentral scotomas that often interfere with reading. The associated classic retinal toxicity is described as a bull’s eye maculopathy (ring of depigmented retinal pigment epithelium that spares the foveal area). Hydroxychloroquine and ocular toxicity recommendations on screening 2009 New Screening Guidelines for Hydroxychloroquine Toxicity, Chloroquine and Hydroxychloroquine Toxicity Guidelines. Sunspots and plaquenilPlaquenil cateratsPlaquenil cause hair lossReading oct screening results plaquenilPlaquenil toxicity fundus Chloroquine and hydroxychloroquine 4‐aminoquinolones are used by dermatologists for the treatment of a wide range of disorders. It is widely recognized that their use may lead to ocular complications. Ocular toxicity and hydroxychloroquine guidelines for.. A Case of Severe Hydroxychloroquine-Induced Retinal.. Retinal toxicity associated with chronic exposure to.. It is thought that although the bull’s eye seen on ophthalmic exam represents a disruption of the pigmented part of the retina, it is the photoreceptors that are the targets of hydroxychloroquine toxicity. Notably the new recommendations were based on a single study published in 2014 that evaluated the prevalence of and risk factors for hydroxychloroquine retinal toxicity. Jan 05, 2020 Hydroxychloroquine is a well-tolerated medication for various rheumatologic and dermatologic conditions. Its main side effects are gastrointestinal upset, skin rash, headache, and ocular toxicity1. Within the eye, hydroxychloroquine can adversely impact the cornea, ciliary body, and retina1 Chloroquine and hydroxychloroquine 4-aminoquinolones are used by dermatologists for the treatment of a wide range of disorders. It is widely recognized that their use may lead to ocular complications, but policies for ophthalmological screening and follow-up vary widely.